Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 10
1996 15
1997 15
1998 17
1999 32
2000 35
2001 53
2002 79
2003 66
2004 76
2005 86
2006 71
2007 79
2008 108
2009 131
2010 131
2011 142
2012 135
2013 150
2014 144
2015 146
2016 151
2017 118
2018 113
2019 114
2020 117
2021 124
2022 111
2023 80
2024 76
2025 84
2026 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,586 results

Results by year

Filters applied: . Clear all
Page 1
Glatiramer acetate: A complex drug beyond biologics.
Rocco P, Eberini I, Musazzi UM, Franzè S, Minghetti P. Rocco P, et al. Eur J Pharm Sci. 2019 May 15;133:8-14. doi: 10.1016/j.ejps.2019.03.011. Epub 2019 Mar 19. Eur J Pharm Sci. 2019. PMID: 30902653 Free article. Review.
In the case of Non Biological Complex Drugs (NBCDs), complexity may arise either from the active substance, as in the case of glatiramer acetate, or from other sources, such as the formulation, as in the case of liposomes. In this paper, the case of glatiramer …
In the case of Non Biological Complex Drugs (NBCDs), complexity may arise either from the active substance, as in the case of glatiramer …
Glatiramer Acetate: from Bench to Bed and Back.
Arnon R, Aharoni R. Arnon R, et al. Isr Med Assoc J. 2019 Mar;21(3):151-157. Isr Med Assoc J. 2019. PMID: 30905097 Free article. Review.
Glatiramer acetate (GA, Copaxone , Copolymer1, Cop 1) is an approved drug for the treatment of relapsing-remitting multiple sclerosis (RRMS). ...
Glatiramer acetate (GA, Copaxone , Copolymer1, Cop 1) is an approved drug for the treatment of relapsing-remitting multiple sc …
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.
Kasindi A, Fuchs DT, Koronyo Y, Rentsendorj A, Black KL, Koronyo-Hamaoui M. Kasindi A, et al. Cells. 2022 May 7;11(9):1578. doi: 10.3390/cells11091578. Cells. 2022. PMID: 35563884 Free PMC article.
Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate-GA) are being examined, primarily in neurological conditions involving cognitive decline. ...
Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate-GA) are being examined, primarily in neurological co …
Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.
Aharoni R, Milo R, Arnon R. Aharoni R, et al. Pharmacol Rev. 2024 Oct 16;76(6):1133-1158. doi: 10.1124/pharmrev.124.000927. Pharmacol Rev. 2024. PMID: 39406508 Review.
Modification of the natural history of MS by reducing relapses and slowing disability accumulation was first attained in the 1990 s with the development of the first-generation disease-modifying therapies. Glatiramer acetate (GA), a copolymer of L-alanine, L-lysine, …
Modification of the natural history of MS by reducing relapses and slowing disability accumulation was first attained in the 1990 s with the …
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
McKeage K. McKeage K. CNS Drugs. 2015 May;29(5):425-32. doi: 10.1007/s40263-015-0245-z. CNS Drugs. 2015. PMID: 25906331 Review.
Glatiramer acetate (Copaxone( )) is a synthetic analogue of myelin basic protein, which is thought to be involved in the pathogenesis of multiple sclerosis (MS). ...Recently, a high-concentration formulation of glatiramer acetate 40 mg/mL administered …
Glatiramer acetate (Copaxone( )) is a synthetic analogue of myelin basic protein, which is thought to be involved in the patho …
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.
Simpson D, Noble S, Perry C. Simpson D, et al. CNS Drugs. 2002;16(12):825-50. doi: 10.2165/00023210-200216120-00004. CNS Drugs. 2002. PMID: 12421116 Review.
Data from the active-treatment extension of the US trial suggest that glatiramer acetate has sustained clinical benefits up to 8 years. Glatiramer acetate was generally well tolerated; the most commonly reported treatment-related adverse events were lo …
Data from the active-treatment extension of the US trial suggest that glatiramer acetate has sustained clinical benefits up to …
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.
Boster AL, Ford CC, Neudorfer O, Gilgun-Sherki Y. Boster AL, et al. Expert Rev Neurother. 2015 Jun;15(6):575-86. doi: 10.1586/14737175.2015.1040768. Epub 2015 Apr 30. Expert Rev Neurother. 2015. PMID: 25924547 Review.
Glatiramer acetate (GA) is approved for relapsing-remitting multiple sclerosis in 57 countries worldwide, with more than 2 million patient-years of exposure and over 20 years of continuous clinical use without new safety concerns. ...
Glatiramer acetate (GA) is approved for relapsing-remitting multiple sclerosis in 57 countries worldwide, with more than 2 mil …
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS. Lalive PH, et al. CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000. CNS Drugs. 2011. PMID: 21476611 Free PMC article. Review.
Glatiramer acetate is a synthetic, random copolymer widely used as a first-line agent for the treatment of relapsing-remitting multiple sclerosis (MS). ...To date, glatiramer acetate-mediated modulation of antigen-presenting cells (APC) such as monocyt …
Glatiramer acetate is a synthetic, random copolymer widely used as a first-line agent for the treatment of relapsing-remitting …
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action.
Farina C, Weber MS, Meinl E, Wekerle H, Hohlfeld R. Farina C, et al. Lancet Neurol. 2005 Sep;4(9):567-75. doi: 10.1016/S1474-4422(05)70167-8. Lancet Neurol. 2005. PMID: 16109363 Review.
Glatiramer acetate is a synthetic random copolymer approved for the immunomodulatory therapy of relapsing-type multiple sclerosis (MS). ...Finally, we will think about how a better understanding of glatiramer acetate might help the development of new i …
Glatiramer acetate is a synthetic random copolymer approved for the immunomodulatory therapy of relapsing-type multiple sclero …
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Fragoso YD. Fragoso YD. Expert Opin Drug Saf. 2014 Dec;13(12):1743-8. doi: 10.1517/14740338.2014.955849. Epub 2014 Sep 1. Expert Opin Drug Saf. 2014. PMID: 25176273 Review.
AREAS COVERED: This paper reviews the literature on pregnancies where the mother was exposed to glatiramer acetate . Few data are available on paternal exposure, but this does not seem to pose a problem due to the pharmacological characteristics of the drug. ...EXPE …
AREAS COVERED: This paper reviews the literature on pregnancies where the mother was exposed to glatiramer acetate . Few data …
2,586 results